Biological Technicians at Genzyme Corporation — H1B Salary Data
Salary Analysis: Biological Technicians at Genzyme Corporation
Genzyme Corporation has filed 5 H1B labor condition applications for Biological Technicians (SOC 19-4021) positions. The average salary offered on these applications is $49,217, with salaries ranging from $43,638 to $52,936.
Compared to the BLS national median salary of $38,860 for Biological Technicians, Genzyme Corporation's H1B salary offers are +26.7% Above Market. This comparison helps assess whether the employer's compensation is competitive with the broader market rate for this occupation. The prevailing wage for this role is a key factor in H1B salary determinations.
The average prevailing wage on these applications is $49,217, which represents the Department of Labor's benchmark for this occupation and work location. Understanding the relationship between offered salary and prevailing wage is critical for H1B compliance.
Nationally, Biological Technicians positions have 11,107 total H1B filings with an average salary of $44,458. Genzyme Corporation is one of multiple employers sponsoring H1B workers for this role. View the H1B visa guide for details on sponsorship eligibility and the approval process.
Salary Comparison: Genzyme Corporation vs BLS National Data
How does Genzyme Corporation's H1B salary for Biological Technicians compare to the Bureau of Labor Statistics national wage distribution? This table shows the employer's offered salary alongside BLS benchmarks.
| Metric | Employer (H1B) | BLS National |
|---|---|---|
| Average / Mean | $49,217 | $41,430 |
| Minimum / 10th Percentile | $43,638 | $37,650 |
| Maximum / 90th Percentile | $52,936 | $44,810 |
| Median | — | $38,860 |
BLS data represents national salary distribution for Biological Technicians across all industries. Total national employment: 600 workers. Source: Bureau of Labor Statistics, Occupational Employment and Wage Statistics.
Recent H1B Filings: Biological Technicians at Genzyme Corporation
The following table shows recent labor condition applications filed by Genzyme Corporation for Biological Technicians positions. There are 5 filings total.
| Case # | Status | Job Title | Salary | Location | Date |
|---|---|---|---|---|---|
| I-200-10221-852808 | Certified | RESEARCH ASSOCIATE SENIOR | $52,936 – $58,002 | FRAMINGHAM, MA | 2013-05-20 |
| I-200-10183-969271 | Certified | RESEARCH ASSOCIATE | $52,936 – $58,960 | FRAMINGHAM, MA | 2013-05-20 |
| I-200-11073-722244 | Certified | RESEARCH ASSOCIATE | $52,936 – $55,000 | FRAMINGHAM, MA | 2011-03-22 |
| I-200-10279-740204 | Certified | PROCESS ENGINEER I | $43,638 – $65,000 | ALLSTON, MA | 2010-10-13 |
| I-200-10274-054564 | Withdrawn | PROCESS ENGINEER I | $43,638 – $72,000 | ALLSTON, MA | 2010-10-06 |
Other Positions at Genzyme Corporation
Besides Biological Technicians, Genzyme Corporation sponsors H1B workers for these occupations.
| Job Title | LCAs | Avg Salary | Market Median | vs Market |
|---|---|---|---|---|
| Compliance Officers, Except Agriculture, Construct | 46 | $73,684 | $59,900 | +23.0% Above Market |
| Chemical Engineers | 24 | $79,704 | $94,920 | -16.0% Below Market |
| Biochemists and Biophysicists | 24 | $72,041 | $132,500 | -45.6% Below Market |
| Chemists | 15 | $63,117 | $95,800 | -34.1% Below Market |
| Statisticians | 13 | $95,576 | $118,560 | -19.4% Below Market |
Other Employers Hiring Biological Technicians
These employers also sponsor H1B workers for Biological Technicians positions. Compare salary offers across different companies.
| Employer | State | LCAs | Avg Salary | Market Median | vs Market |
|---|---|---|---|---|---|
| Dana-Farber Cancer Institute | MA | 488 | $45,434 | $38,860 | +16.9% Above Market |
| University of Pittsburgh | PA | 455 | $38,674 | $38,860 | -0.5% At Market |
| Baylor College of Medicine | TX | 236 | $41,669 | $38,860 | +7.2% Above Market |
| Memorial Sloan Kettering Cancer Center | NY | 229 | $53,080 | $38,860 | +36.6% Above Market |
| Trustees of the University of Pennsylvania | PA | 203 | $44,270 | $38,860 | +13.9% Above Market |